Researchers studied 304 people who received kidney transplants to understand how vitamin D levels affect their health. They found that 84% of these patients didn’t have enough vitamin D in their blood. Low vitamin D was connected to higher levels of a hormone called PTH that controls bone health. While vitamin D deficiency was very common, it had only weak connections to inflammation markers in the blood. The study suggests that checking vitamin D levels regularly and making sure transplant patients get enough of this important nutrient might help them stay healthier, especially for their bones.
The Quick Take
- What they studied: Whether vitamin D levels in kidney transplant patients are connected to inflammation and other health markers in their blood
- Who participated: 304 adult patients who had kidney transplants at one medical center between 2015 and 2025. Most were vitamin D deficient (below 20 ng/mL)
- Key finding: 84% of kidney transplant patients had low vitamin D levels, and those with low vitamin D had significantly higher PTH hormone levels (a sign of bone problems). However, vitamin D showed only weak connections to most inflammation markers
- What it means for you: If you’ve had a kidney transplant, your doctor should check your vitamin D levels regularly. Getting enough vitamin D may help protect your bones and overall health, though it’s just one piece of the puzzle for staying healthy after transplant
The Research Details
This was a retrospective study, which means researchers looked back at medical records from patients who had already received kidney transplants. They reviewed information from 304 patients seen at one transplant center over a 10-year period (2015-2025). The researchers divided patients into two groups based on their vitamin D levels: those with deficiency (less than 20 ng/mL) and those without deficiency (20 ng/mL or higher). They then compared blood test results between these groups, looking at inflammation markers and other health measurements.
The researchers used standard statistical tests to find connections between vitamin D levels and various blood markers. They measured inflammation using several different blood tests, including neutrophil-to-lymphocyte ratio (a comparison of two types of white blood cells), platelet-to-lymphocyte ratio (comparing platelets to white blood cells), C-reactive protein, and other markers that show inflammation in the body.
This approach is useful because it allows researchers to study real-world patterns in a large group of patients over many years. By looking at actual medical records, they can see what naturally happens in transplant patients without doing experiments that might be risky. Understanding these patterns helps doctors know what to monitor and treat in their transplant patients.
The study included a reasonably large group of 304 patients, which gives the findings more reliability. However, because it’s a retrospective study looking at past records rather than a controlled experiment, we can’t be completely certain about cause-and-effect relationships. The study was done at a single medical center, so results might be different in other hospitals or countries. The very high rate of vitamin D deficiency (84%) is striking and reliable, but the weak connections found with inflammation markers suggest vitamin D is just one of many factors affecting inflammation in transplant patients.
What the Results Show
The most important finding was that vitamin D deficiency is extremely common in kidney transplant patients—84% of the 304 patients studied had low vitamin D levels. This is much higher than in the general population, suggesting that kidney transplant patients have special needs for vitamin D monitoring.
When researchers compared patients with low vitamin D to those with adequate levels, they found a clear connection: patients with low vitamin D had significantly higher levels of PTH (parathyroid hormone). PTH is a hormone that controls calcium and phosphate balance in your body, and high levels can lead to bone problems. This connection was strong and statistically significant (p = .002), meaning it’s unlikely to be due to chance.
Interestingly, vitamin D showed only weak connections to most inflammation markers that the researchers measured. There were very slight correlations with procalcitonin (a protein that increases with infection) and ESR (erythrocyte sedimentation rate, which measures inflammation), but these were weak relationships. Vitamin D showed no meaningful connection to C-reactive protein, the neutrophil-to-lymphocyte ratio, or the platelet-to-lymphocyte ratio—all common inflammation markers.
The study found no significant associations between vitamin D levels and cholesterol levels (lipid profile) or several other blood parameters measured. This suggests that vitamin D deficiency in transplant patients may have more specific effects on bone metabolism rather than broad effects on multiple body systems. The findings highlight that inflammation in transplant patients is complex and influenced by many different factors beyond just vitamin D.
Previous research has shown that vitamin D plays important roles in immune function and bone health. This study confirms that vitamin D deficiency is particularly common in kidney transplant patients and validates the connection between low vitamin D and high PTH levels, which has been observed in other kidney disease populations. However, the weak correlations with inflammation markers suggest that the relationship between vitamin D and inflammation may be more complicated than previously thought, especially in the unique situation of transplant patients whose immune systems are being suppressed with medications.
This study has several important limitations to consider. First, it only looked at patients from one medical center, so the results might not apply to all transplant patients everywhere. Second, because it’s a retrospective study looking at past records, researchers couldn’t control for all the factors that might affect vitamin D levels or inflammation, such as sun exposure, diet, or specific medications patients were taking. Third, the study couldn’t prove that low vitamin D causes high PTH or inflammation—only that they’re connected. Finally, the very high rate of vitamin D deficiency in this population suggests these patients may have unique characteristics that make them different from other transplant patients.
The Bottom Line
Based on this research, kidney transplant patients should have their vitamin D levels checked regularly as part of routine follow-up care (moderate confidence). If vitamin D deficiency is found, supplementation should be considered, especially to help protect bone health and control PTH levels (moderate confidence). However, vitamin D supplementation alone is not a complete solution for managing inflammation or all health issues in transplant patients—it should be part of a comprehensive care plan (high confidence).
This research is most relevant to people who have received kidney transplants and their transplant doctors. It’s also important for nephrologists (kidney specialists) and primary care doctors who manage transplant patients. The findings suggest that routine vitamin D screening should be standard care for all kidney transplant recipients. People with chronic kidney disease who haven’t had a transplant should also discuss vitamin D status with their doctors, as they may have similar risks.
If vitamin D deficiency is treated with supplements, it typically takes several weeks to months to see improvements in PTH levels and bone metabolism. Most people won’t notice immediate symptoms, but over time, maintaining adequate vitamin D may help prevent bone loss and fractures. Regular blood tests (usually every 3-6 months) can track whether vitamin D supplementation is working.
Want to Apply This Research?
- Track vitamin D supplementation doses and timing daily, and log quarterly vitamin D blood test results and PTH levels to monitor whether supplementation is effectively raising vitamin D and lowering PTH
- Set a daily reminder to take vitamin D supplements at the same time each day (ideally with a meal containing fat for better absorption), and schedule quarterly lab work reminders to check vitamin D and PTH levels
- Create a chart within the app showing vitamin D levels and PTH levels over time (quarterly or every 6 months), with target ranges provided by your transplant doctor. Track any symptoms of bone pain or weakness, and note any changes in vitamin D supplementation doses recommended by your doctor
This research describes patterns observed in kidney transplant patients but does not establish definitive cause-and-effect relationships. The findings are specific to transplant recipients and may not apply to people with other conditions. If you have received a kidney transplant, discuss vitamin D screening and supplementation with your transplant doctor or nephrologist before making any changes to your care plan. Do not start, stop, or change any medications or supplements without consulting your healthcare provider. This information is educational and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.